Browsing Tag
Novartis Pharma AG
3 posts
Will multi-year kidney function data secure Vanrafia’s long-term positioning?
Novartis Pharma AG’s ALIGN data test whether eGFR slope preservation can confirm Vanrafia’s clinical benefit. Read the full executive analysis.
GSK to acquire efimosfermin from Boston Pharmaceuticals for $2bn to bolster liver disease pipeline
GSK acquires Phase III-ready efimosfermin from Boston Pharmaceuticals for $2B, expanding its liver disease pipeline with a fibrosis-reversing specialty drug.
Hikma secures exclusive rights to $436M cancer drug in deal with Novugen
Find out how Hikma is strengthening its US oncology portfolio with exclusive rights to a $436M cancer treatment.